SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-404640
Filing Date
2014-11-10
Accepted
2014-11-10 08:01:54
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d783739d10q.htm 10-Q 239000
2 EX-31.1 d783739dex311.htm EX-31.1 9425
3 EX-31.2 d783739dex312.htm EX-31.2 9426
4 EX-32.1 d783739dex321.htm EX-32.1 4872
5 EX-32.2 d783739dex322.htm EX-32.2 4873
  Complete submission text file 0001193125-14-404640.txt   2429357

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT galt-20140930.xml EX-101.INS 223646
7 XBRL TAXONOMY EXTENSION SCHEMA galt-20140930.xsd EX-101.SCH 31691
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20140930_cal.xml EX-101.CAL 35710
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20140930_def.xml EX-101.DEF 176755
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20140930_lab.xml EX-101.LAB 249202
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20140930_pre.xml EX-101.PRE 210422
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 141206615
SIC: 2834 Pharmaceutical Preparations